NEW YORK–(BUSINESS WIRE)–Ophthotech today announced the completion of patient recruitment in its Phase 3 trial of Fovista® for wet AMD, and that it has achieved a $30 million enrollment milestone from Novartis Pharma AG.
VIDEO: OCT-guided AMD management
KIAWAH ISLAND, S.C. — At the Kiawah Eye meeting, David M. Brown, MD, FACS, discusses the use of OCT to manage patients with age-related macular degeneration.
Could restoring electrical signals help heal diabetic wounds?
Mouse study finds cornea wounds in diabetes have abnormal electric signals and suggests they could be a target in managing slow and non-healing wounds.
Investigation of Vascular Pathology in Eye Diseases Using Using Optical Coherence Tomography Angiography (OCT-A)
Status: Not yet recruiting,
Condition Summary: Retinal Disease
VIDEO: Treatment with aflibercept for recalcitrant DME
KIAWAH ISLAND, S.C. — At the Kiawah Eye meeting, Scott Gardner, MD, discusses his experience with the use of Regeneron’s Eylea (aflibercept) for treating recalcitrant diabetic macular edema.
Five most-viewed cataract-related videos from ASCRS, OIS
June is #CataractAwarenessMonth. The most trending articles on Healio.com/OSN from the American Society of Cataract and Refractive Surgery meeting and the Ophthalmology Innovation Summit were video perspectives from key opinion leaders who shared their…